mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |
mRNA |
YK 4-279 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0008 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0008 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
FH535 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
0.47 |
0.002 |
mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.002 |